Michael Miller
Host, RX Communications
Replay available
Intensity Therapeutics, Inc. (NASDAQ: INTS) Q2 2023 earnings conference call, held 2023-08-14. Replay captured from the company's public earnings webcast.

Host, RX Communications
Founder and Chief Executive Officer
Chief Financial Officer and Principal Accounting Officer
Watch the replay and follow the connected company analysis, news, and investor updates for Intensity Therapeutics, Inc..
WEBVTT 00:00:00.049 -- 00:00:05.800 Good morning and welcome to the Intensity Therapeutics second quarter 2023 00:00:05.851 -- 00:00:08.191 conference call and webcast. 00:00:08.191 -- 00:00:11.132 All participants will be in listen-only mode. 00:00:11.132 -- 00:00:16.253 Should you need assistance, please signal a conference specialist by pressing star then 00:00:16.253 -- 00:00:21.815 zero on your telephone keypad. After today's presentation, there will be an opportunity 00:00:21.815 -- 00:00:27.116 to ask questions. To ask a question, you may press star then one on your telephone 00:00:27.116 -- 00:00:31.925 keypad. To withdraw your question, please press star then two. 00:00:31.925 -- 00:00:36.528 Please note this event is being recorded. I would now like to turn the conference call 00:00:36.528 -- 00:00:40.391 over to our host, Michael Miller of RX Communications. 00:00:40.391 -- 00:00:42.891 Please go ahead. 00:00:43.573 -- 00:00:48.556 Thank you, operator. Good morning, and thank you for joining the Intensity Therapeutics 00:00:48.556 -- 00:00:53.179 conference call to review the financial and operating results for the second quarter 00:00:53.179 -- 00:00:56.702 ended June 30th, 2023. I'm joined today by Lewis H. 00:00:56.702 -- 00:00:58.702 Bender, 00:00:59.215 -- 00:01:04.980 Founder and Chief Executive Officer, and John Wesolowski, Chief Financial Officer. 00:01:04.980 -- 00:01:09.644 As a reminder, this conference call contains forward-looking statements within the meaning 00:01:09.644 -- 00:01:14.828 of the federal securities laws. The company's actual results may differ materially from 00:01:14.828 -- 00:01:17.891 those projected in the forward-looking statements. 00:01:17.891 -- 00:01:23.315 Additional information concerning factors that might cause act...